Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This research is being done to find out if using the contrast agent MultiHance can be used to
show how a liver tumor responds to the chemotherapy given during Transcatheter Arterial
Chemoembolization (TACE).
Phase:
N/A
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins